Euroopa Liit - eesti - EMA (European Medicines Agency)

mylan ireland limited - abirateroonatsetaat - eesnäärmevähk - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Euroopa Liit - eesti - EMA (European Medicines Agency)

krka, d.d., novo mesto - abirateroonatsetaat - eesnäärmevähk - endokriinset ravi - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Euroopa Liit - eesti - EMA (European Medicines Agency)

accord healthcare s.l.u. - abirateroonatsetaat - eesnäärmevähk - endokriinset ravi - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Eesti - eesti - Ravimiamet

norameda uab - abirateroon - õhukese polümeerikattega tablett - 500mg 60tk; 500mg 56tk

Eesti - eesti - Ravimiamet

teva b.v. - abirateroon - õhukese polümeerikattega tablett - 500mg 14tk

Eesti - eesti - Ravimiamet

olainfarm as - abirateroon - õhukese polümeerikattega tablett - 500mg 56tk; 500mg 60tk

Eesti - eesti - Ravimiamet

olainfarm as - abirateroon - tablett - 250mg 120tk

Eesti - eesti - Ravimiamet

stada arzneimittel ag - abirateroon - õhukese polümeerikattega tablett - 500mg 56tk; 500mg 10tk

Eesti - eesti - Ravimiamet

stada arzneimittel ag - abirateroon - õhukese polümeerikattega tablett - 250mg 14tk; 250mg 120tk

Eesti - eesti - Ravimiamet

g.l. pharma gmbh - abirateroon - õhukese polümeerikattega tablett - 500mg 56tk